Vivos Therapeutics, Inc. (VVOS) vs Beyond Air, Inc. (XAIR)
A side-by-side comparison of Vivos Therapeutics, Inc. and Beyond Air, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
VVOS
Vivos Therapeutics, Inc.
$0.15HealthcareDelayed quote: Oct 6, 2026, 3:50 PM EDT
XAIR
Beyond Air, Inc.
$2.61HealthcareDelayed quote: Oct 6, 2026, 3:49 PM EDT
Total return — VVOS vs XAIR
growth of $100 · dividends reinvested · last 6yVVOS -99.9% (-70.3%/yr)XAIR -99.9% (-66.9%/yr)XAIR compounded faster over this window
VVOS XAIR
VVOS vs XAIR: by the numbers
- •VVOS is the larger company ($2M vs $2M market cap).
- •Both run net losses; VVOS's is the smaller (-122.42% vs -435.71% net margin).
- •XAIR grew revenue faster over the past five years (64.21% vs 7.52% CAGR).
Metrics side by side
Valuation
| Metric | VVOS | XAIR |
|---|---|---|
| P/S ratio | 0.10 | 0.24 |
Profitability
| Metric | VVOS | XAIR |
|---|---|---|
| Gross margin | 59.72% | 4.18% |
| Operating margin | -107.92% | -378.23% |
| Net margin | -122.42% | -435.71% |
| ROE | N/A | -1677.17% |
| ROIC | -182.30% | -106.06% |
Growth (annualized)
| Metric | VVOS | XAIR |
|---|---|---|
| Revenue CAGR (5Y) | 7.52% | 64.21% |
| Total return CAGR (5Y) | -72.60% | -76.73% |
Frequently asked
- Which has grown faster, VVOS or XAIR?
- Over the past five years, XAIR grew revenue faster — VVOS at a 7.52% CAGR versus XAIR at 64.21%.
- How have VVOS and XAIR total returns compared?
- Over the past 5 years, VVOS delivered -72.60% and XAIR delivered -76.73% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Vivos Therapeutics ROEBeyond Air ROEVivos Therapeutics operating marginBeyond Air operating marginVivos Therapeutics revenue growthBeyond Air revenue growthVivos Therapeutics free cash flowBeyond Air free cash flow
Vivos Therapeutics & Beyond Air appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.